&w=3840&q=100)
Earthquake of magnitude 4.1 strikes Myanmar, no casualties reported
As per the NCS, the earthquake happened at a shallow depth of 10km, making it susceptible to aftershocks.
In a post on X, the NCS said, " EQ of M: 4.1, On: 03/07/2025 06:10:48 IST, Lat: 22.01 N, Long: 95.58 E, Depth: 10 Km, Location: Myanmar."
Shallow earthquakes are generally more dangerous than deep earthquakes. This is because the seismic waves from shallow earthquakes have a shorter distance to travel to the surface, resulting in stronger ground shaking and potentially more damage to structures and greater casualties.
Earlier on July 1, another earthquake of 4.2 magnitude on the Richter Scale struck the region at a depth of 135km.
In a post on X, the NCS said, "EQ of M: 4.2, On: 01/07/2025 08:14:16 IST, Lat: 24.92 N, Long: 95.39 E, Depth: 135 Km, Location: Myanmar."
On June 25, an earthquake measuring 136km on the Richter Scale struck Myanmar.
In a post on X, the NCS said, "EQ of M: 3.9, On: 25/06/2025 13:01:48 IST, Lat: 22.56 N, Long: 95.74 E, Depth: 136 Km, Location: Myanmar."
In the aftermath of the magnitude 7.7 and 6.4 earthquakes that struck central Myanmar on March 28, the World Health Organization (WHO) warned of a series of rapidly rising health threats for tens of thousands of displaced people in earthquake-affected areas: tuberculosis (TB), HIV, vector- and water-borne diseases.
Myanmar is vulnerable to hazards from moderate and large magnitude earthquakes, including tsunami hazards along its long coastline.
The Sagaing Fault elevates the seismic hazard for Sagaing, Mandalay, Bago, and Yangon, which together represent 46 per cent of the population of Myanmar. Although Yangon is relatively far from the fault trace, it still suffers from significant risk due to its dense population. For instance, in 1903, an intense earthquake with a magnitude of 7.0 that occurred in Bago also struck Yangon.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
The Hindu
14 hours ago
- The Hindu
WHO pushes countries to raise prices on sugary drinks, alcohol and tobacco by 50%
The World Health Organization (WHO) is pushing countries to raise the prices of sugary drinks, alcohol and tobacco by 50% over the next 10 years through taxation, its strongest backing yet for taxes to help tackle chronic public health problems. The United Nations health agency said the move would help cut consumption of the products, which contribute to diseases like diabetes and some cancers, as well as raising money at a time when development aid is shrinking and public debt rising."Health taxes are one of the most efficient tools we have," said Jeremy Farrar, WHO assistant-director general of health promotion and disease prevention and control. "It's time to act." The WHO launched the push, which it called "3 by 35" at the UN Finance for Development conference in Seville. WHO said that its tax initiative could raise $1 trillion by 2035 based on evidence from health taxes in countries such as Colombia and South Africa. The WHO has backed tobacco taxes and price rises for decades, and has called for taxes on alcohol and sugary drinks in recent years, but this is the first time it has suggested a target price rise for all three products. WHO Director-General Tedros Adhanom Ghebreyesus told the conference that the taxes could help governments "adjust to the new reality" and bolster their own health systems with the money raised. Many low and middle-income countries are coping with cuts to aid spending led by the United States, which is not attending the Seville conference. The U.S. is also in the process of withdrawing from the WHO. From $4 to $10 As an example, the initiative would mean a government in a middle-income country raising taxes on the product to push the price up from $4 today to $10 by 2035, taking into account inflation, said WHO health economist Guillermo Sandoval. Nearly 140 countries had already raised tobacco taxes and therefore prices by over 50% on average between 2012 and 2022, the WHO added. Sandoval said the WHO was also considering broader taxation recommendations, including on ultra-processed food, after the agency finalises its definition of that type of food in the coming months. But he added that the agency expected pushback from the industries involved. 'It's deeply concerning that the WHO continues to disregard over a decade of clear evidence showing that taxing sugar-sweetened beverages has never improved health outcomes or reduced obesity in any country,' said Kate Loatman, executive director of the International Council of Beverages Associations, adding that the industry was working on options to support health. 'The WHO's suggestion that raising taxes will prevent alcohol-related harm is misguided,'said Amanda Berger, senior vice president of science and research at the Distilled Spirits Council, adding that it would not prevent alcohol abuse. The tax initiative is backed by Bloomberg Philanthropies, the World Bank and the Organization for Economic Co-operation and Development (OECD), and involves support for countries who want to take action.
Indian Express
18 hours ago
- Indian Express
Vaccine manufacturers' body, Serum Institute of India reaffirm COVID-19 vaccine safety
The Indian Vaccine Manufacturers Association (IVMA) has assured that all COVID-19 vaccines in India were approved for emergency use authorisation based on extensive evaluation in preclinical studies and human clinical trials. 'Patient safety and product quality are always prioritised during the vaccine development and its manufacture,' Dr G V J A Harshavardhan, Director General, IVMA, said in a statement released on Thursday. The statement sought to reassure the public on the safety and efficacy of COVID-19 vaccines. 'All COVID-19 vaccines in India were approved for emergency use authorisation [restricted use in emergency situations as per World Health Organization guidelines], he said, adding, 'These approvals were based on extensive evaluation in preclinical studies and human clinical trials, with positive results on safety, efficacy, and immunogenicity of these vaccines.' The IVMA statement comes in the backdrop of the Union health ministry saying on Wednesday that extensive studies by several agencies have 'conclusively established no linkages' between COVID-19 vaccines and sudden deaths. The Serum Institute of India also posted on X that the COVID-19 vaccines were safe and scientifically validated. 'Two large-scale studies by ICMR [Indian Council of Medical Research] and AIIMS [All India Institute of Medical Sciences], as cited by the Ministry of Health have found no link between Covid-19 vaccines and sudden deaths,' SII said. The IVMA statement also noted that prior to their release, all COVID-19 vaccines were tested extensively for safety by the manufacturers and were also provided Batch Release Certification by the Central Drugs Laboratory in Kasauli, Himachal Pradesh, under the Ministry of Health and Family Welfare. 'The strengths of innovation and large-scale, high-quality manufacturing are the hallmarks of the Indian vaccine ecosystem. COVID-19 vaccines manufactured in India were largely responsible for not only controlling the COVID-19 pandemic and restricting its impact on lives, livelihoods, but most importantly, enabling India's economic activity and GDP to rebound and grow to new heights globally,' Dr Harshavardhan said. 'This positive impact of COVID-19 vaccination was not only limited to India, but also to several countries worldwide, under the Government of India's Vaccine Maitri programme…,' he added.
Deccan Herald
a day ago
- Deccan Herald
WHO to document Karnataka's 'Asha Kirana' as global eye care model
The World Health Organization (WHO) has expressed interest in Karnataka's 'Asha Kirana' initiative, which provides doorstep eye care, and plans to share its success story with other countries and regions. The WHO has proposed a comprehensive assessment of the initiative to further strengthen the programme and generate valuable insights and best practices for other regions aiming to implement integrated, people-centred eye care. In a letter to Harsh Gupta, Principal Secretary of Health and Family Welfare, WHO Representative to India, Dr Roderico H Ofrin, appreciated the state government for conceptualising and effectively implementing the 'Asha Kirana' initiative. "This innovative model, launched under your leadership, marks significant progress towards eliminating avoidable blindness and ensuring equitable access to comprehensive eye care across the state. We are particularly encouraged by how 'Asha Kirana' aligns with the WHO's Integrated People-Centred Eye Care (IPEC) framework," Ofrin wrote in the letter dated June 30. Recognising its impact and scalability, the WHO expressed keen interest in systematically documenting the state's model. Such an evaluation, Ofrin noted, will help strengthen the programme while providing lessons and best practices for other regions and countries.
